End of paragraph 2 gives the answer as to why the urgency-
The government money being used to fund the development is “matched funding” so to get the money they have to have the money!!! Which they don’t currently have.
I wonder have still thought debt was a better alternative and obviously Hawkesbury and Cannacord set the pricing to make their job easier. We shouldn’t have had to offer such a big discount on such an already stuffed share price.
DR needs to come back with some REAL news to get the price moving again or the rights issue will be a no go. If he brings back big news it might be worth something.
I hope the new institutions and sophisticated have been vetted to be holders not traders or who knows how low this can go !!!!
Euan I would have thought would be better connected to managing capital than to get us into this deepening mess.
- Forums
- ASX - By Stock
- ADO
- Ann: AnteoTech $3.5m Placement, launch of $5m Entitlement Offer
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.4¢

Ann: AnteoTech $3.5m Placement, launch of $5m Entitlement Offer, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.87M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $34.97K | 2.366M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1034040 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 4088579 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1034040 | 0.014 |
5 | 412252 | 0.013 |
10 | 2536827 | 0.012 |
8 | 2805359 | 0.011 |
6 | 3159000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 4088579 | 10 |
0.016 | 1427582 | 2 |
0.017 | 198800 | 3 |
0.018 | 1215334 | 6 |
0.019 | 617333 | 7 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online